Cargando…
Warfarin Anticoagulant Therapy: A Southern Italy Pharmacogenetics-Based Dosing Model
BACKGROUND AND AIM: Warfarin is the most frequently prescribed anticoagulant worldwide. However, warfarin therapy is associated with a high risk of bleeding and thromboembolic events because of a large interindividual dose-response variability. We investigated the effect of genetic and non genetic f...
Autores principales: | Mazzaccara, Cristina, Conti, Valeria, Liguori, Rosario, Simeon, Vittorio, Toriello, Mario, Severini, Angelo, Perricone, Corrado, Meccariello, Alfonso, Meccariello, Pasquale, Vitale, Dino Franco, Filippelli, Amelia, Sacchetti, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753327/ https://www.ncbi.nlm.nih.gov/pubmed/23990957 http://dx.doi.org/10.1371/journal.pone.0071505 |
Ejemplares similares
-
Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile
por: Di Maso, Vittorio, et al.
Publicado: (2014) -
Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of Warfarin
por: Kangelaris, Kirsten Neudoerffer, et al.
Publicado: (2009) -
Pharmacogenetics of Anticoagulants
por: Rane, Anders, et al.
Publicado: (2010) -
Systematic Review of Pharmacogenetic Warfarin Dosing
por: van Schie, Rianne M. F., et al.
Publicado: (2009) -
VKORC1 Pharmacogenetics and Pharmacoproteomics in Patients on Warfarin Anticoagulant Therapy: Transthyretin Precursor as a Potential Biomarker
por: Saminathan, Ramasamy, et al.
Publicado: (2010)